Heart rehab at home: App-Based program aims to shrink artery plaque

NCT ID NCT07660419

Recruiting now Disease control Sponsor: China National Center for Cardiovascular Diseases Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a home-based cardiac rehab program delivered through a mobile app can reduce plaque buildup in the heart arteries of people with mild to moderate blockages. 176 participants will either get the app-based program (with exercise plans, diet advice, and mental health support) or standard care. The main goal is to see if plaque volume changes after 12 months, with follow-up lasting 3 years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mobile health-based cardiac rehabilitation program (exercise, nutrition, and psychological support via a smartphone app)
What this could lead to: If it works, this could offer a convenient, at-home way to slow or reverse plaque buildup in heart arteries, potentially reducing the need for more invasive procedures.
What could go wrong: This is a relatively small, early-stage trial (176 people) testing a behavioral intervention, so results may not apply to everyone. The program relies on patient motivation and adherence, which can be challenging at home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE (CAD) CORONARY STENOSIS

Contacts and locations

Locations

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
RECRUITING

Beijing, 100037, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.